• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mural Oncology plc - Ordinary Shares (NQ: MURA )

    3.280 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 204
    Open 3.280
    Bid (Size) 3.080 (2)
    Ask (Size) 3.790 (5)
    Prev. Close 3.280
    Today's Range 3.280 - 3.280
    52wk Range 2.880 - 17.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
    MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
    From Mural Oncology, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -45.15%
    -45.15%
    1 Month
    -4.93%
    -4.93%
    3 Month
    -8.64%
    -8.64%
    6 Month
    -29.46%
    -29.46%
    1 Year
    -13.68%
    -13.68%

    More News

    Read More
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
    From Mural Oncology, Inc.
    Via GlobeNewswire
    MURA Stock Earnings: Mural Oncology Reported Results for Q1 2024
    Via InvestorPlace
    MURA Stock Earnings: Mural Oncology Reported Results for Q4 2023
    Via InvestorPlace
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    MURA Stock Earnings: Mural Oncology Reported Results for Q3 2023
    Via InvestorPlace
    Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
    Via InvestorPlace
    The 3 Most Undervalued Biotech Stocks to Buy in January
    Via InvestorPlace
    Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.